28 A landmark pilot study that investigated the efficacy and safety of 72-h GLP-1 RA infusion in patients with acute MI and impaired LVEF ( 12 weeks) to non-diabetic, overweight or obese individuals with HF (NYHA Class IIIII) and LVEF below 40%
Both Novo Nordisk and Eli Lilly caution that their weight loss drugs may cause serious side effects, including the potential risk of thyroid tumors
I went to Drip Gym and that changed everything
According to a 2022 study, most people experience diarrhea for about 3 days when they first begin semaglutide treatment
Do not change the dose on your own A clinician may hold escalation, extend time at a dose, reduce a dose, review meal size and constipation, check another diagnosis, or change treatment
10.1016/j.bpsc.2018.02.007 112